{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:41:57Z","timestamp":1771663317816,"version":"3.50.1"},"reference-count":63,"publisher":"Bentham Science Publishers Ltd.","issue":"10","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Cancer is a deadly disease that has claimed millions of lives worldwide. Traditional cancer\ntreatments, such as chemotherapy and radiation, have been used for many years but have become\nless favored due to drug resistance, lack of tumor selectivity, high costs, and various side effects,\nsuch as fatigue and hair loss. Many studies have reported that animal venoms, such as those\nfrom snakes, scorpions, and bees, contain bioactive peptides that can be synthesized into anti--\ncancer peptides (ACPs), which offer a potential alternative to traditional cancer therapies. Apitherapy\nis an area of growing interest for the development of new cancer treatments using bee venom,\nwhich is a complex mixture of biologically active peptides, enzymes, bioactive amines, and nonpeptide\ncomponents that have been found to have anti-cancer properties. By leveraging these\nbioactive peptides, researchers could develop ACPs that are more targeted towards cancer cells, reducing\nthe risk of adverse side effects and improving patient outcomes. The use of bee venom\ncomponents in targeting cancer could provide a more selective, effective, and affordable approach\nto cancer therapy. While further research is needed, the potential benefits of using bee venom components\nin cancer therapy are significant and could help improve the lives of cancer patients worldwide.\nThis study aims to review the components of bee venom as potential cancer treatments.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0109298665339355241008104141","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T05:26:37Z","timestamp":1731993997000},"page":"796-805","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Honeybee Venom: A Potential Source of Anticancer Components"],"prefix":"10.2174","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4053-5603","authenticated-orcid":true,"given":"Sabrina Xin Yi","family":"Khor","sequence":"first","affiliation":[{"name":"School of Biosciences, Faculty of Health and Medical Sciences, Taylor's University, 47500 Subang Jaya, Selangor\nDarul Ehsan, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4548-2790","authenticated-orcid":true,"given":"Kitiphong","family":"Khongphinitbunjong","sequence":"additional","affiliation":[{"name":"School of Science, Mae Fah Luang University, Chiang Rai 57100, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6926-5849","authenticated-orcid":true,"given":"Amorn","family":"Owatworakit","sequence":"additional","affiliation":[{"name":"School of Science, Mae Fah Luang University, Chiang Rai 57100, Thailand"},{"name":"Microbial Product\nand Innovation Research Group, Mae Fah Luang University, Chiang Rai 57100, Thailand;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siau Hui","family":"Mah","sequence":"additional","affiliation":[{"name":"School of Biosciences, Faculty of Health and Medical Sciences, Taylor's University, 47500 Subang Jaya, Selangor\nDarul Ehsan, Malaysia"},{"name":"Digital Health and\nMedical Advancement Impact Lab, Taylor's University, 47500 Subang Jaya, Selangor Darul Ehsan, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7327-2830","authenticated-orcid":true,"given":"Yin-Quan","family":"Tang","sequence":"additional","affiliation":[{"name":"School of Biosciences, Faculty of Health and Medical Sciences, Taylor's University, 47500 Subang Jaya, Selangor\nDarul Ehsan, Malaysia"},{"name":"Digital Health and\nMedical Advancement Impact Lab, Taylor's University, 47500 Subang Jaya, Selangor Darul Ehsan, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"Bray F.","year":"2024","unstructured":"Bray F.; Laversanne M.; Sung H.; Ferlay J.; Siegel R.L.; Soerjomataram I.; Jemal A.; Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin  2024,74(3),229-263","journal-title":"CA Cancer J Clin"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"Sung H.","year":"2021","unstructured":"Sung H.; Ferlay J.; Siegel R.L.; Laversanne M.; Soerjomataram I.; Jemal A.; Bray F.; Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin  2021,71(3),209-249","journal-title":"CA Cancer J Clin"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1002\/cam4.2474","volume":"8","author":"Dillek\u00e5s H.","year":"2019","unstructured":"Dillek\u00e5s H.; Rogers M.S.; Straume O.; Are 90% of deaths from cancer caused by metastases? Cancer Med  2019,8(12),5574-5576","journal-title":"Cancer Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.20517\/cdr.2019.10","volume":"2","author":"Wang X.","year":"2019","unstructured":"Wang X.; Zhang H.; Chen X.; Drug resistance and combating drug resistance in cancer. Cancer Drug Resist  2019,2(2),141-160","journal-title":"Cancer Drug Resist"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12929-017-0328-x","volume":"24","author":"Marqus S.","year":"2017","unstructured":"Marqus S.; Pirogova E.; Piva T.J.; Evaluation of the use of therapeutic peptides for cancer treatment. J Biomed Sci  2017,24(1),21","journal-title":"J Biomed Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"e73957","DOI":"10.1371\/journal.pone.0073957","volume":"8","author":"Gupta S.","year":"2013","unstructured":"Gupta S.; Kapoor P.; Chaudhary K.; Gautam A.; Kumar R.; Raghava G.P.S.; Raghava G.P.; In silico approach for predicting toxicity of peptides and proteins. PLoS One  2013,8(9),e73957","journal-title":"PLoS One"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2174\/0929866527666200409102747","volume":"27","author":"Soon T.N.","year":"2020","unstructured":"Soon T.N.; Chia A.Y.Y.; Yap W.H.; Tang Y.Q.; Anticancer mechanisms of bioactive peptides. Protein Pept Lett  2020,27(9),823-830","journal-title":"Protein Pept Lett"},{"key":"ref=8","first-page":"8","volume":"1","author":"Soon T.N.","year":"2020","unstructured":"Soon T.N.; Chia A.Y.Y.; Yap W.H.; Tang Y.Q.; Animal Venom-derived Antimicrobial Peptides: Novel and Improved Weapon for Cancer Treatment Malaysian Journal for Biochemistry and. Mol Biol  2020,1,8","journal-title":"Mol Biol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/leu.2016.254","volume":"31","author":"Qazilbash M.H.","year":"2017","unstructured":"Qazilbash M.H.; Wieder E.; Thall P.F.; Wang X.; Rios R.; Lu S.; Kanodia S.; Ruisaard K.E.; Giralt S.A.; Estey E.H.; Cortes J.; Komanduri K.V.; Clise-Dwyer K.; Alatrash G.; Ma Q.; Champlin R.E.; Molldrem J.J.; PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies. Leukemia  2017,31(3),697-704","journal-title":"Leukemia"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/ph15020222","volume":"15","author":"Al Shaer D.","year":"2022","unstructured":"Al Shaer D.; Al Musaimi O.; Albericio F.; de la Torre B.G.; 2021 FDA tides (peptides and oligonucleotides) harvest. Pharmaceuticals  2022,15(2),222","journal-title":"Pharmaceuticals"},{"key":"ref=11a","doi-asserted-by":"publisher","first-page":"e0255753","DOI":"10.1371\/journal.pone.0255753","volume":"17","author":"Wijesinghe A.","year":"2022","unstructured":"Wijesinghe A.; Kumari S.; Booth V.; Conjugates for use in peptide therapeutics: A systematic review and meta-analysis. PLoS One  2022,17(3),e0255753","journal-title":"PLoS One"},{"key":"ref=11b","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.3390\/pharmaceutics15082093","volume":"15","author":"Zhang H.","year":"2023","unstructured":"Zhang H.; Zhang Y.; Zhang C.; Yu H.; Ma Y.; Li Z.; Shi N.; Recent Advances of Cell-Penetrating Peptides and Their Application as Vectors for Delivery of Peptide and Protein-Based Cargo Molecules. Pharmaceutics  2023,15(8),2093","journal-title":"Pharmaceutics"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"100908","DOI":"10.18632\/oncotarget.21740","volume":"8","author":"Ma R.","year":"2017","unstructured":"Ma R.; Mahadevappa R.; Kwok H.F.; Venom-based peptide therapy: insights into anti-cancer mechanism. Oncotarget  2017,8(59),100908-100930","journal-title":"Oncotarget"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.2174\/1568026619666181221120817","volume":"18","author":"Chatterjee B.","year":"2019","unstructured":"Chatterjee B.; Animal venoms have potential to treat cancer. Curr Top Med Chem  2019,18(30),2555-2566","journal-title":"Curr Top Med Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/sj.bjc.6601617","volume":"90","author":"Bleumer I.","year":"2004","unstructured":"Bleumer I.; Knuth A.; Oosterwijk E.; Hofmann R.; Varga Z.; Lamers C.; Kruit W.; Melchior S.; Mala C.; Ullrich S.; Mulder P.D.; Mulders P F A.; Beck J.; A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients. Br J Cancer  2004,90(5),985-990","journal-title":"Br J Cancer"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.1074\/jbc.M807191200","volume":"284","author":"Wang C.","year":"2009","unstructured":"Wang C.; Chen T.; Zhang N.; Yang M.; Li B.; L\u00fc X.; Cao X.; Ling C.; Melittin, a major component of bee venom, sensitizes human hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating CaMKII-TAK1-JNK\/p38 and inhibiting IkappaBalpha kinase-NFkappaB. J Biol Chem  2009,284(6),3804-3813","journal-title":"J Biol Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1517\/17425255.2012.664636","volume":"8","author":"Valerio L.G.","year":"2012","unstructured":"Valerio L.G.; Application of advanced in silico methods for predictive modeling and information integration. Expert Opin Drug Metab Toxicol  2012,8(4),395-398","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1038\/srep02984","volume":"3","author":"Tyagi A.","year":"2013","unstructured":"Tyagi A.; Kapoor P.; Kumar R.; Chaudhary K.; Gautam A.; Raghava G.P.S.; In silico models for designing and discovering novel anticancer peptides. Sci Rep  2013,3(1),2984","journal-title":"Sci Rep"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.1177\/1534735420944476","volume":"19","author":"El Bakary N.M.","year":"2020","unstructured":"El Bakary N.M.; Alsharkawy A.Z.; Shouaib Z.A.; Barakat E.M.S.; Role of bee venom and melittin on restraining angiogenesis and metastasis in \u03b3-irradiated solid ehrlich carcinoma-bearing mice. Integr Cancer Ther  2020,19,4476","journal-title":"Integr Cancer Ther"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/toxins16030117","volume":"16","author":"Gajski G.","year":"2024","unstructured":"Gajski G.; Leonova E.; Sjakste N.; Bee venom: Composition and anticancer properties. Toxins  2024,16(3),117","journal-title":"Toxins"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"5703","DOI":"10.1364\/BOE.9.005703","volume":"9","author":"Jung G.B.","year":"2018","unstructured":"Jung G.B.; Huh J.E.; Lee H.J.; Kim D.; Lee G.J.; Park H.K.; Lee J.D.; Anti-cancer effect of bee venom on human MDA-MB-231 breast cancer cells using Raman spectroscopy. Biomed Opt Express  2018,9(11),5703-5718","journal-title":"Biomed Opt Express"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.semcancer.2015.02.006","author":"Feitelson M.A.","year":"2015","unstructured":"Feitelson M.A.; Arzumanyan A.; Kulathinal R.J.; Blain S.W.; Holcombe R.F.; Mahajna J.; Marino M.; Martinez-Chantar M.L.; Nawroth R.; Sanchez-Garcia I.; Sharma D.; Saxena N.K.; Singh N.; Vlachostergios P.J.; Guo S.; Honoki K.; Fujii H.; Georgakilas A.G.; Bilsland A.; Amedei A.; Niccolai E.; Amin A.; Ashraf S.S.; Boosani C.S.; Guha G.; Ciriolo M.R.; Aquilano K.; Chen S.; Mohammed S.I.; Azmi A.S.; Bhakta D.; Halicka D.; Keith W.N.; Nowsheen S.; Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin Cancer Biol  2015,S25-S54","journal-title":"Semin Cancer Biol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.3390\/ijms19103041","volume":"19","author":"Kim M.","year":"2018","unstructured":"Kim M.; Kang N.; Ko S.; Park J.; Park E.; Shin D.; Kim S.; Lee S.; Lee J.; Lee S.; Ha E.; Jeon S.; Park Y.; Antibacterial and antibiofilm activity and mode of action of magainin 2 against drug-resistant Acinetobacter baumannii. Int J Mol Sci  2018,19(10),3041","journal-title":"Int J Mol Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3390\/cancers12051172","volume":"12","author":"Saman H.","year":"2020","unstructured":"Saman H.; Raza S.S.; Uddin S.; Rasul K.; Inducing angiogenesis, a key step in cancer vascularization, and treatment approaches. Cancers (Basel)  2020,12(5),1172","journal-title":"Cancers (Basel)"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1021\/np300446c","volume":"75","author":"Huh J.E.","year":"2012","unstructured":"Huh J.E.; Kang J.W.; Nam D.; Baek Y.H.; Choi D.Y.; Park D.S.; Lee J.D.; Melittin suppresses VEGF-A-induced tumor growth by blocking VEGFR-2 and the COX-2-mediated MAPK signaling pathway. J Nat Prod  2012,75(11),1922-1929","journal-title":"J Nat Prod"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3390\/biom11081120","volume":"11","author":"Bakare O.O.","year":"2021","unstructured":"Bakare O.O.; Gokul A.; Wu R.; Niekerk L.A.; Klein A.; Keyster M.; Biomedical relevance of novel anticancer peptides in the sensitive treatment of cancer. Biomolecules  2021,11(8),1120","journal-title":"Biomolecules"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.3390\/molecules25122850","volume":"25","author":"Tornesello A.L.","year":"2020","unstructured":"Tornesello A.L.; Borrelli A.; Buonaguro L.; Buonaguro F.M.; Tornesello M.L.; Antimicrobial peptides as anticancer agents: Functional properties and biological activities. Molecules  2020,25(12),2850","journal-title":"Molecules"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"200004","DOI":"10.1098\/rsob.200004","volume":"10","author":"Xie M.","year":"2020","unstructured":"Xie M.; Liu D.; Yang Y.; Anti-cancer peptides: classification, mechanism of action, reconstruction and modification. Open Biol  2020,10(7),200004","journal-title":"Open Biol"},{"key":"ref=28","author":"Tanu S.","year":"2022","unstructured":"Tanu S.; Princy C.; Sangeeta S.; Antimicrobial Peptides: Mechanism of Action. Insights on Antimicrobial Peptides  2022","journal-title":"Insights on Antimicrobial Peptides"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"10841","DOI":"10.1038\/s41598-019-47325-y","volume":"9","author":"Pandidan S.","year":"2019","unstructured":"Pandidan S.; Mechler A.; Nano-viscosimetry analysis of the membrane disrupting action of the bee venom peptide melittin. Sci Rep  2019,9(1),10841","journal-title":"Sci Rep"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"001","DOI":"10.47755\/2766-9653.1000104","volume":"1","author":"Yavari M.","year":"2020","unstructured":"Yavari M.; Salesi Z.; Derakhti A.; Melittin and breast cancer a brief review of the evidence. J Nurs Patient Saf  2020,1,001-007","journal-title":"J Nurs Patient Saf"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"e01945","DOI":"10.1002\/brb3.1945","volume":"11","author":"Soltan-Alinejad P.","year":"2021","unstructured":"Soltan-Alinejad P.; Vahedi M.; Turki H.; Soltani A.; A comprehensive entomological survey and evaluation of the efficacy of different therapies on a suspected delusional parasitosis case. Brain Behav  2021,11(1),e01945","journal-title":"Brain Behav"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.canlet.2017.05.010","volume":"402","author":"Rady I.","year":"2017","unstructured":"Rady I.; Siddiqui I.A.; Rady M.; Mukhtar H.; Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer Lett  2017,402,16-31","journal-title":"Cancer Lett"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41698-020-00129-0","volume":"4","author":"Duffy C.","year":"2020","unstructured":"Duffy C.; Sorolla A.; Wang E.; Golden E.; Woodward E.; Davern K.; Ho D.; Johnstone E.; Pfleger K.; Redfern A.; Iyer K.S.; Baer B.; Blancafort P.; Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer. NPJ Precis Oncol  2020,4(1),24","journal-title":"NPJ Precis Oncol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/pros.21296","volume":"71","author":"Park M.H.","year":"2011","unstructured":"Park M.H.; Choi M.S.; Kwak D.H.; Oh K.W.; Yoon D.Y.; Han S.B.; Song H.S.; Song M.J.; Hong J.T.; Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-\u03baB. Prostate  2011,71(8),801-812","journal-title":"Prostate"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/cancers11081109","volume":"11","author":"Shaw P.","year":"2019","unstructured":"Shaw P.; Kumar N.; Hammerschmid D.; Privat-Maldonado A.; Dewilde S.; Bogaerts A.; Synergistic effects of melittin and plasma treatment: A promising approach for cancer therapy. Cancers (Basel)  2019,11(8),1109","journal-title":"Cancers (Basel)"},{"key":"ref=36","first-page":"22","volume":"3","author":"Alizadehnohi M.","year":"2012","unstructured":"Alizadehnohi M.; Nabiuni M.; Nazari Z.; Safaeinejad Z.; Irian S.; The synergistic cytotoxic effect of cisplatin and honey bee venom on human ovarian cancer cell line A2780cp. J Venom Res  2012,3,22-27","journal-title":"J Venom Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.taap.2011.10.009","volume":"258","author":"Jo M.","year":"2012","unstructured":"Jo M.; Park M.H.; Kollipara P.S.; An B.J.; Song H.S.; Han S.B.; Kim J.H.; Song M.J.; Hong J.T.; Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2\/STAT3 pathway. Toxicol Appl Pharmacol  2012,258(1),72-81","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1002\/hep.22240","volume":"47","author":"Liu S.","year":"2008","unstructured":"Liu S.; Yu M.; He Y.; Xiao L.; Wang F.; Song C.; Sun S.; Ling C.; Xu Z.; Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway. Hepatology  2008,47(6),1964-1973","journal-title":"Hepatology"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/jpp\/rgad008","volume":"75","author":"Luo Y.","year":"2023","unstructured":"Luo Y.; Xu C.; Luo B.; Liang G.; Zhang Q.; Melittin treatment prevents colorectal cancer from progressing in mice through ER stress-mediated apoptosis. J Pharm Pharmacol  2023,75(5),645-654","journal-title":"J Pharm Pharmacol"},{"key":"ref=40a","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nature10933","volume":"486","author":"Shah S.P.","year":"2012","unstructured":"Shah S.P.; Roth A.; Goya R.; Oloumi A.; Ha G.; Zhao Y.; Turashvili G.; Ding J.; Tse K.; Haffari G.; Bashashati A.; Prentice L.M.; Khattra J.; Burleigh A.; Yap D.; Bernard V.; McPherson A.; Shumansky K.; Crisan A.; Giuliany R.; Heravi-Moussavi A.; Rosner J.; Lai D.; Birol I.; Varhol R.; Tam A.; Dhalla N.; Zeng T.; Ma K.; Chan S.K.; Griffith M.; Moradian A.; Cheng S.W.G.; Morin G.B.; Watson P.; Gelmon K.; Chia S.; Chin S.F.; Curtis C.; Rueda O.M.; Pharoah P.D.; Damaraju S.; Mackey J.; Hoon K.; Harkins T.; Tadigotla V.; Sigaroudinia M.; Gascard P.; Tlsty T.; Costello J.F.; Meyer I.M.; Eaves C.J.; Wasserman W.W.; Jones S.; Huntsman D.; Hirst M.; Caldas C.; Marra M.A.; Aparicio S.; The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature  2012,486(7403),395-399","journal-title":"Nature"},{"key":"ref=40b","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.molonc.2010.11.003","volume":"5","author":"Prat A.","year":"2011","unstructured":"Prat A.; Perou C.M.; Deconstructing the molecular portraits of breast cancer. Mol Oncol  2011,5(1),5-23","journal-title":"Mol Oncol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"847","DOI":"10.21037\/jgo-22-222","volume":"13","author":"Zhao J.","year":"2022","unstructured":"Zhao J.; Hu W.; Zhang Z.; Zhou Z.; Duan J.; Dong Z.; Liu H.; Yan C.; Bee venom protects against pancreatic cancer via inducing cell cycle arrest and apoptosis with suppression of cell migration. J Gastrointest Oncol  2022,13(2),847-858","journal-title":"J Gastrointest Oncol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/gb4184","volume":"15","author":"Malumbres M.","year":"2014","unstructured":"Malumbres M.; Cyclin-dependent kinases. Genome Biol  2014,15(6),122","journal-title":"Genome Biol"},{"key":"ref=43","first-page":"515","volume":"25","author":"Qian Y.","year":"2010","unstructured":"Qian Y.; Chen X.; Tumor suppression by p53: making cells senescent. Histol Histopathol  2010,25(4),515-526","journal-title":"Histol Histopathol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12575-020-00133-5","volume":"22","author":"Sadeghi F.","year":"2020","unstructured":"Sadeghi F.; Asgari M.; Matloubi M.; Ranjbar M.; Karkhaneh Yousefi N.; Azari T.; Zaki-Dizaji M.; Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: review of radiosensitivity assays. Biol Proced Online  2020,22(1),23","journal-title":"Biol Proced Online"},{"key":"ref=45","first-page":"276","volume":"8","author":"Tariq R.","year":"2021","unstructured":"Tariq R.; Liaqat A.; Khalid U.; An insight into the role of bee venom and melittin against tumor cells: A review of breast cancer therapy. Arch Breast Cancer  2021,8(4),276","journal-title":"Arch Breast Cancer"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"7424","DOI":"10.48048\/tis.2024.7424","volume":"21","author":"Plasay M.","year":"2024","unstructured":"Plasay M.; Muslimin L.; Potential natural toxin with anticancer properties: Regulating IL-1\u03b2, COX-2 and TNF-\u03b1 in human colorectal cancer cells WiDr. Trends Sci  2024,21(4),7424","journal-title":"Trends Sci"},{"key":"ref=47","doi-asserted-by":"publisher","DOI":"10.32388\/0Y7O4S","author":"Celik S.","year":"2024","unstructured":"Celik S.; Anti-metastasis after bee venom and melittin by upregulation of BRMS1 and DRG1 genes, with downregulation of wnt7b in breast cancer cells. Qeios  2024","journal-title":"Qeios"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3390\/molecules23030692","volume":"23","author":"Moga M.","year":"2018","unstructured":"Moga M.; Dimienescu O.; Arv\u0103tescu C.; Ifteni P.; Ple\u015f L.; Anticancer activity of toxins from bee and snake venom\u2014an overview on ovarian cancer. Molecules  2018,23(3),692","journal-title":"Molecules"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12645-021-00085-9","volume":"12","author":"Dabbagh Moghaddam F.","year":"2021","unstructured":"Dabbagh Moghaddam F.; Akbarzadeh I.; Marzbankia E.; Farid M.; khaledi L.; Reihani A.H.; Javidfar M.; Mortazavi P.; Delivery of melittin-loaded niosomes for breast cancer treatment: An in vitro and in vivo evaluation of anti-cancer effect. Cancer Nanotechnol  2021,12(1),14","journal-title":"Cancer Nanotechnol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s43141-020-00112-z","volume":"19","author":"Darwish D.A.","year":"2021","unstructured":"Darwish D.A.; Masoud H.M.M.; Abdel-Monsef M.M.; Helmy M.S.; Zidan H.A.; Ibrahim M.A.; Phospholipase A2 enzyme from the venom of Egyptian honey bee Apis mellifera lamarckii with anti-platelet aggregation and anti-coagulation activities. J Genet Eng Biotechnol  2021,19(1),10","journal-title":"J Genet Eng Biotechnol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3390\/toxins13080521","volume":"13","author":"Chaisakul J.","year":"2021","unstructured":"Chaisakul J.; Khow O.; Wiwatwarayos K.; Rusmili M.R.A.; Prasert W.; Othman I.; Abidin S.A.Z.; Charoenpitakchai M.; Hodgson W.C.; Chanhome L.; Chaiyabutr N.; A biochemical and pharmacological characterization of phospholipase a and metalloproteinase fractions from eastern russell\u2019s viper (Daboia siamensis) venom: Two major components associated with acute kidney injury. Toxins (Basel)  2021,13(8),521","journal-title":"Toxins (Basel)"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1007\/s00262-006-0143-9","volume":"55","author":"Putz T.","year":"2006","unstructured":"Putz T.; Ramoner R.; Gander H.; Rahm A.; Bartsch G.; Thurnher M.; Antitumor action and immune activation through cooperation of bee venom secretory phospholipase A2 and phosphatidylinositol-(3,4)-bisphosphate. Cancer Immunol Immunother  2006,55(11),1374-1383","journal-title":"Cancer Immunol Immunother"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.3390\/molecules26082264","volume":"26","author":"Yaacoub C.","year":"2021","unstructured":"Yaacoub C.; Rifi M.; El-Obeid D.; Mawlawi H.; Sabatier J.M.; Coutard B.; Fajloun Z.; The cytotoxic effect of Apis mellifera venom with a synergistic potential of its two main components-melittin and pla2-on colon cancer hct116 cell lines. Molecules  2021,26(8),2264","journal-title":"Molecules"},{"key":"ref=54","first-page":"833","volume":"28","author":"Ip S.W.","year":"2008","unstructured":"Ip S.W.; Wei H.C.; Lin J.P.; Kuo H.M.; Liu K.C.; Hsu S.C.; Yang J.S.; Mei-Dueyang ; Chiu T.H.; Han S.M.; Chung J.G.; Bee venom induced cell cycle arrest and apoptosis in human cervical epidermoid carcinoma Ca Ski cells. Anticancer Res  2008,28(2A),833-842","journal-title":"Anticancer Res"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.3390\/molecules29163950","volume":"29","author":"Chahla C.","year":"2024","unstructured":"Chahla C.; Rima M.; Mouawad C.; Roufayel R.; Kovacic H.; El Obeid D.; Sabatier J-M.; Luis J.; Fajloun Z.; El-Waly B.; Effect of Apis mellifera syriaca bee venom on glioblastoma cancer: In vitro and in vivo studies. Molecules  2024,29(16),3950","journal-title":"Molecules"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"27067","DOI":"10.1074\/jbc.M110.110072","volume":"285","author":"Lamy C.","year":"2010","unstructured":"Lamy C.; Goodchild S.J.; Weatherall K.L.; Jane D.E.; Li\u00e9geois J.F.; Seutin V.; Marrion N.V.; Allosteric block of KCa2 channels by apamin. J Biol Chem  2010,285(35),27067-27077","journal-title":"J Biol Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/toxins12030195","volume":"12","author":"Gu H.","year":"2020","unstructured":"Gu H.; Han S.M.; Park K.K.; Therapeutic effects of apamin as a bee venom component for non-neoplastic disease. Toxins  2020,12(3),195","journal-title":"Toxins"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/bph.13357","volume":"173","author":"Abdulkareem Z.A.","year":"2016","unstructured":"Abdulkareem Z.A.; Gee J.M.W.; Cox C.D.; Wann K.T.; Knockdown of the small conductance Ca -activated K channels is potently cytotoxic in breast cancer cell lines. Br J Pharmacol  2016,173(1),177-190","journal-title":"Br J Pharmacol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1158\/1535-7163.MCT-06-0194","volume":"5","author":"Potier M.","year":"2006","unstructured":"Potier M.; Joulin V.; Roger S.; Besson P.; Jourdan M.L.; LeGuennec J.Y.; Bougnoux P.; Vandier C.; Identification of SK3 channel as a new mediator of breast cancer cell migration. Mol Cancer Ther  2006,5(11),2946-2953","journal-title":"Mol Cancer Ther"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3390\/ph14080729","volume":"14","author":"Alhakamy N.A.","year":"2021","unstructured":"Alhakamy N.A.; Ahmed O.A.A.; Fahmy U.A.; Md S.; Apamin-conjugated alendronate sodium nanocomplex for management of pancreatic cancer. Pharmaceuticals  2021,14(8),729","journal-title":"Pharmaceuticals"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"668992","DOI":"10.3389\/fonc.2021.668992","volume":"11","author":"Yang W.","year":"2021","unstructured":"Yang W.; Zhang Y.; Yang G.; Geng Y.; Chen D.; Wang J.; Ye Y.; Wang H.; Xia D.; Hu F.; Jiang J.; Xu X.; Anti-PD-1 immunotherapy and bee venom for relapsed and refractory liposarcoma: A case report. Front Oncol  2021,11,668992","journal-title":"Front Oncol"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298665339355241008104141","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/236333\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298665339355241008104141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T10:55:55Z","timestamp":1737024955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/236333\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":63,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298665339355241008104141","relation":{},"ISSN":["0929-8665"],"issn-type":[{"value":"0929-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-06-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}